In this video, the performance of the COVID serological test is shown through a tutorial.

The Rapid COVID-19 qSARS-CoV-2 test for the detection of IgG/IgM antibodies is a lateral flow immunoassay for the qualitative detection of antibodies against the novel coronavirus 2019 (SARS-CoV-2) in whole blood samples obtained by fingerstick.

It is intended to be used as an aid in the diagnosis of viral infections caused by SARS-CoV-2. These tests detect specific antibodies against the SARS-CoV-2 virus produced by the patient. They provide information about the phase of the infection by distinguishing between IgG and IgM anti-SARS-CoV-2.

The COVID-19 qSARS-CoV-2 antibody rapid tests offer a sensitivity of 93.7% and a specificity of 96.4%.